| Title |
Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery
|
|---|---|
| Published in |
Journal of Neuro-Oncology, July 2011
|
| DOI | 10.1007/s11060-011-0650-1 |
| Pubmed ID | |
| Authors |
Mark R. Gilbert, John Kuhn, Kathleen R. Lamborn, Frank Lieberman, Patrick Y. Wen, Minesh Mehta, Timothy Cloughesy, Andrew B. Lassman, Lisa M. DeAngelis, Susan Chang, Michael Prados |
Mendeley readers
The data shown below were compiled from readership statistics for 109 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 2% |
| United Kingdom | 2 | 2% |
| Netherlands | 1 | <1% |
| Germany | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 102 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 24 | 22% |
| Student > Bachelor | 16 | 15% |
| Researcher | 14 | 13% |
| Student > Master | 8 | 7% |
| Student > Doctoral Student | 6 | 6% |
| Other | 20 | 18% |
| Unknown | 21 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 33 | 30% |
| Agricultural and Biological Sciences | 16 | 15% |
| Biochemistry, Genetics and Molecular Biology | 8 | 7% |
| Chemistry | 8 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 5% |
| Other | 12 | 11% |
| Unknown | 27 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 November 2021.
All research outputs
#3,214,626
of 26,017,215 outputs
Outputs from Journal of Neuro-Oncology
#220
of 3,329 outputs
Outputs of similar age
#15,760
of 132,245 outputs
Outputs of similar age from Journal of Neuro-Oncology
#4
of 27 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,329 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 132,245 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.